Literature DB >> 12089073

New treatments for atopic dermatitis.

Hywel Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089073      PMCID: PMC1123485          DOI: 10.1136/bmj.324.7353.1533

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

1.  SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis.

Authors:  T Luger; E J Van Leent; M Graeber; S Hedgecock; M Thurston; A Kandra; J Berth-Jones; J Bjerke; E Christophers; J Knop; A C Knulst; M Morren; A Morris; S Reitamo; J Roed-Petersen; E Schoepf; K Thestrup-Pedersen; P G Van Der Valk; J D Bos
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

Review 2.  Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.

Authors:  Paul Nghiem; Greg Pearson; Richard G Langley
Journal:  J Am Acad Dermatol       Date:  2002-02       Impact factor: 11.527

3.  Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

Authors:  H Williams; C Robertson; A Stewart; N Aït-Khaled; G Anabwani; R Anderson; I Asher; R Beasley; B Björkstén; M Burr; T Clayton; J Crane; P Ellwood; U Keil; C Lai; J Mallol; F Martinez; E Mitchell; S Montefort; N Pearce; J Shah; B Sibbald; D Strachan; E von Mutius; S K Weiland
Journal:  J Allergy Clin Immunol       Date:  1999-01       Impact factor: 10.793

4.  Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease.

Authors:  P D Arkwright; T J David
Journal:  J Allergy Clin Immunol       Date:  2001-03       Impact factor: 10.793

5.  Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.

Authors:  M Kalliomäki; S Salminen; H Arvilommi; P Kero; P Koskinen; E Isolauri
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

6.  The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study.

Authors:  C Queille-Roussel; C Paul; L Duteil; M C Lefebvre; G Rapatz; M Zagula; J P Ortonne
Journal:  Br J Dermatol       Date:  2001-03       Impact factor: 9.302

7.  Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

Authors:  Sakari Reitamo; Edwin J M Van Leent; Vincent Ho; John Harper; Thomas Ruzicka; Kirsti Kalimo; Frédéric Cambazard; Malcolm Rustin; Alain Taïeb; David Gratton; Daniel Sauder; Graham Sharpe; Catherine Smith; Michael Jünger; Yves de Prost
Journal:  J Allergy Clin Immunol       Date:  2002-03       Impact factor: 10.793

8.  Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis.

Authors:  Sakari Reitamo; Malcolm Rustin; Thomas Ruzicka; Frédéric Cambazard; Kirsti Kalimo; Peter S Friedmann; Erwin Schoepf; Mourad Lahfa; Thomas L Diepgen; Harryono Judodihardjo; Andreas Wollenberg; John Berth-Jones; Thomas Bieber
Journal:  J Allergy Clin Immunol       Date:  2002-03       Impact factor: 10.793

Review 9.  Systematic review of treatments for atopic eczema.

Authors:  C Hoare; A Li Wan Po; H Williams
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

  9 in total
  7 in total

1.  Topical corticosteroids in atopic dermatitis.

Authors:  David J Atherton
Journal:  BMJ       Date:  2003-10-25

2.  Risk: benefit ratio is important in treating atopic dermatitis.

Authors:  B Roger Allen; Thomas A Luger
Journal:  BMJ       Date:  2002-10-26

Review 3.  Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.

Authors:  Dene Simpson; Stuart Noble
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.

Authors:  Darren M Ashcroft; Paul Dimmock; Ruth Garside; Ken Stein; Hywel C Williams
Journal:  BMJ       Date:  2005-02-24

5.  A Herbal Formula, Atofreellage, Ameliorates Atopic Dermatitis-Like Skin Lesions in an NC/Nga Mouse Model.

Authors:  Won-Yong Kim; Hyeong-Geug Kim; Hye-Won Lee; Jin-Seok Lee; Hwi-Jin Im; Hyo-Seon Kim; Sung-Bae Lee; Chang-Gue Son
Journal:  Molecules       Date:  2015-12-25       Impact factor: 4.411

6.  Pimecrolimus cream 1% in the management of atopic dermatitis in pediatric patients: a meta-analysis.

Authors:  Chunyun Huang; Youyu Sheng
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

7.  Anti-Atopic Properties of Gracillin Isolated from Dioscorea quinqueloba on 2,4-Dinitrochlorobenzene-Induced Skin Lesions in Mice.

Authors:  Jonghwan Jegal; No-June Park; Beom-Geun Jo; Sim-Kyu Bong; Hyun Jegal; Min Hye Yang; Su-Nam Kim
Journal:  Nutrients       Date:  2018-09-01       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.